|
PNN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.180200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5333999999998E-05 |
| Normal-vs-Stage2 |
6.579800E-02 |
| Normal-vs-Stage3 |
8.720300E-02 |
| Normal-vs-Stage4 |
2.188200E-01 |
| Stage1-vs-Stage2 |
5.305800E-01 |
| Stage1-vs-Stage3 |
9.938100E-02 |
| Stage1-vs-Stage4 |
9.471900E-02 |
| Stage2-vs-Stage3 |
5.813000E-01 |
| Stage2-vs-Stage4 |
4.921200E-01 |
| Stage3-vs-Stage4 |
8.282200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.762070E-03 |
| Normal-vs-AfricanAmerican |
3.184200E-03 |
| Normal-vs-Asian |
3.96010000014435E-07 |
| Caucasian-vs-AfricanAmerican |
7.944100E-02 |
| Caucasian-vs-Asian |
2.160100E-02 |
| AfricanAmerican-vs-Asian |
1.722590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.596400E-02 |
| Normal-vs-Female |
3.77380000027294E-07 |
| Male-vs-Female |
4.799800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.370200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.991800E-04 |
| Normal-vs-Age(61-80Yrs) |
3.624200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.289400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.850400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.354800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.279400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.339600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.477000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.230200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.962100E-04 |
| Normal-vs-Grade 2 |
1.70655999999214E-05 |
| Normal-vs-Grade 3 |
5.746000E-02 |
| Normal-vs-Grade 4 |
6.017200E-01 |
| Grade 1-vs-Grade 2 |
3.310100E-02 |
| Grade 1-vs-Grade 3 |
1.323420E-03 |
| Grade 1-vs-Grade 4 |
1.099780E-03 |
| Grade 2-vs-Grade 3 |
1.453790E-02 |
| Grade 2-vs-Grade 4 |
1.349770E-02 |
| Grade 3-vs-Grade 4 |
4.218600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.01220000048308E-07 |
| Normal-vs-ccB subtype |
3.104000E-01 |
| ccA subtype-vs-ccB subtype |
1.751190E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.876060E-03 |
| Normal-vs-N1 |
9.445600E-01 |
| N0-vs-N1 |
2.638600E-01 |
|
|
